Potassium binder may ease the burden of dietary potassium restriction in people on dialysis
Dietary potassium restriction is important for managing hyperkalemia, or high blood potassium levels, in individuals on maintenance hemodialysis, but it imposes a substantial day-to-day burden. Results from a recent clinical trial indicate that adding the potassium binder sodium zirconium cyclosilicate (SZC) may help. The findings will be presented at ASN Kidney Week 2026, Oct. 22–25.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
A study of 802 teens raises questions about school breakfast and blood sugar
United Kingdom
-
Researchers show how leukemia cells 'hide' from treatment
United Kingdom
-
Scientists studied one million immune cells and found clues to future disease risk
United Kingdom
-
A Towering Figure of Tolerance From 2,500 Years Ago Has Found a New Home in Atlanta
United Kingdom
-
Clinical support tool helps primary care health professionals detect and treat chronic kidney disease
United Kingdom
-
Fruits and vegetables outperform medication for treating metabolic acidosis in chronic kidney disease
United Kingdom
-
Social determinants linked with kidney failure risk among survivors of critical illness and acute kidney injury
United Kingdom
-
Standardized kidney biopsy protocol is safe in high-risk patients
United Kingdom